DocGo (DCGO) Competitors $4.46 +0.07 (+1.59%) (As of 11:58 AM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends DCGO vs. FTRE, VRDN, AHCO, CDNA, PNTG, AVAH, AGL, CSTL, GRAL, and INNVShould you be buying DocGo stock or one of its competitors? The main competitors of DocGo include Fortrea (FTRE), Viridian Therapeutics (VRDN), AdaptHealth (AHCO), CareDx (CDNA), The Pennant Group (PNTG), Aveanna Healthcare (AVAH), agilon health (AGL), Castle Biosciences (CSTL), Grail (GRAL), and InnovAge (INNV). These companies are all part of the "healthcare" industry. DocGo vs. Fortrea Viridian Therapeutics AdaptHealth CareDx The Pennant Group Aveanna Healthcare agilon health Castle Biosciences Grail InnovAge DocGo (NASDAQ:DCGO) and Fortrea (NASDAQ:FTRE) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, media sentiment, risk, valuation, community ranking, institutional ownership, profitability, dividends and analyst recommendations. Does the MarketBeat Community favor DCGO or FTRE? DocGo received 33 more outperform votes than Fortrea when rated by MarketBeat users. Likewise, 74.58% of users gave DocGo an outperform vote while only 25.58% of users gave Fortrea an outperform vote. CompanyUnderperformOutperformDocGoOutperform Votes4474.58% Underperform Votes1525.42% FortreaOutperform Votes1125.58% Underperform Votes3274.42% Do analysts recommend DCGO or FTRE? DocGo currently has a consensus target price of $6.10, suggesting a potential upside of 36.77%. Fortrea has a consensus target price of $23.30, suggesting a potential upside of 20.91%. Given DocGo's stronger consensus rating and higher probable upside, analysts clearly believe DocGo is more favorable than Fortrea.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score DocGo 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00Fortrea 1 Sell rating(s) 11 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.92 Which has higher earnings and valuation, DCGO or FTRE? DocGo has higher earnings, but lower revenue than Fortrea. Fortrea is trading at a lower price-to-earnings ratio than DocGo, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDocGo$694.97M0.65$6.86M$0.2815.93Fortrea$2.98B0.58-$3.40M-$3.42-5.63 Is DCGO or FTRE more profitable? DocGo has a net margin of 4.35% compared to Fortrea's net margin of -10.99%. DocGo's return on equity of 8.90% beat Fortrea's return on equity.Company Net Margins Return on Equity Return on Assets DocGo4.35% 8.90% 5.72% Fortrea -10.99%2.00%0.80% Do institutionals & insiders have more ownership in DCGO or FTRE? 56.4% of DocGo shares are held by institutional investors. 2.7% of DocGo shares are held by insiders. Comparatively, 0.1% of Fortrea shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has more volatility and risk, DCGO or FTRE? DocGo has a beta of 0.98, indicating that its stock price is 2% less volatile than the S&P 500. Comparatively, Fortrea has a beta of 1.16, indicating that its stock price is 16% more volatile than the S&P 500. Does the media refer more to DCGO or FTRE? In the previous week, DocGo had 7 more articles in the media than Fortrea. MarketBeat recorded 8 mentions for DocGo and 1 mentions for Fortrea. DocGo's average media sentiment score of 0.53 beat Fortrea's score of -0.04 indicating that DocGo is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DocGo 2 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Fortrea 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryDocGo beats Fortrea on 16 of the 18 factors compared between the two stocks. Ad Crypto 101 MediaTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW Get DocGo News Delivered to You Automatically Sign up to receive the latest news and ratings for DCGO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DCGO vs. The Competition Export to ExcelMetricDocGoHealth services IndustryMedical SectorNASDAQ ExchangeMarket Cap$455.15M$890.26M$5.13B$9.28BDividend YieldN/A1.87%4.81%4.06%P/E Ratio15.9337.30135.2417.51Price / Sales0.654.111,174.53134.92Price / Cash19.4425.0440.4837.95Price / Book1.523.024.884.94Net Income$6.86M-$5.79M$118.56M$225.30M7 Day Performance7.73%-4.18%14.97%-1.11%1 Month Performance11.50%0.16%15.07%7.29%1 Year Performance-7.66%368.27%34.31%23.06% DocGo Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DCGODocGo2.7232 of 5 stars$4.46+1.6%$6.10+36.8%-12.0%$455.15M$694.97M15.934,164Insider TradeNews CoverageFTREFortrea2.6532 of 5 stars$20.15+0.8%$23.30+15.6%-39.0%$1.81B$3.11B-5.8518,000VRDNViridian Therapeutics3.0903 of 5 stars$22.50+26.1%$36.33+61.5%+8.3%$1.78B$310,000.00-5.2950Analyst ForecastNews CoverageHigh Trading VolumeAHCOAdaptHealth3.0107 of 5 stars$10.14+6.2%$11.67+15.1%+29.7%$1.36B$3.26B-5.7910,700CDNACareDx3.7754 of 5 stars$22.68-0.8%$29.60+30.5%+122.1%$1.22B$280.32M-8.35740Short Interest ↑PNTGThe Pennant Group4.2562 of 5 stars$29.79+2.3%$38.25+28.4%+116.4%$1.02B$544.89M42.815,791Positive NewsAVAHAveanna Healthcare0.7718 of 5 stars$5.00-0.6%$4.27-14.7%+101.7%$966.13M$1.98B-14.7933,500Short Interest ↑AGLagilon health2.4299 of 5 stars$2.23-0.4%$4.28+92.1%-84.7%$918.80M$5.59B-2.381,117Analyst ForecastShort Interest ↑News CoverageCSTLCastle Biosciences2.6446 of 5 stars$28.77-0.3%$39.71+38.0%+40.2%$805.76M$311.88M144.35540Short Interest ↑GRALGrail0.4571 of 5 stars$22.91+3.4%$16.00-30.2%N/A$769.80M$117.67M0.001,360INNVInnovAge1.449 of 5 stars$4.48+0.9%$6.50+45.1%-28.3%$606.84M$786.51M-37.002,350Analyst ForecastNews CoveragePositive News Related Companies and Tools Related Companies FTRE Alternatives VRDN Alternatives AHCO Alternatives CDNA Alternatives PNTG Alternatives AVAH Alternatives AGL Alternatives CSTL Alternatives GRAL Alternatives INNV Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:DCGO) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersThis drone stock is setting up to transform medical supply deliveryDrone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.The Tomorrow Investor | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | SponsoredWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Behind the Markets | SponsoredMissed Nvidia? Buy Elon Musk’s “Silent Partner”In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my f...Brownstone Research | Sponsored50-year Wall Street legend: “Sell this tech stock NOW”Something very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DocGo Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DocGo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DCGO Stock Alerts